SEANIA BRISTOL: Open Payments
NPI 1992301188 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,630 in 189 payments from 23 companies in 2025. Trend: 2023 $1,896 · 2024 $1,505 · 2025 $4,630
Food & beverage: $4,540Education: $90
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 12 | $809 |
| Janssen Biotech, Inc. | 20 | $785 |
| ABBVIE INC. | 33 | $569 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $281 |
| PFIZER INC. | 15 | $277 |
| QOL Medical, LLC | 10 | $261 |
| GENZYME CORPORATION | 4 | $178 |
| Ardelyx, Inc. | 10 | $155 |
| Celltrion USA Inc. | 9 | $154 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $144 |
Products named: REZDIFFRA, TREMFYA, DUPIXENT, RINVOQ, ENTYVIO, Sucraid, VELSIPITY, IBSRELA.
Industry payments across AZ — which companies pay providers there.
